Stay updated on Ampyra Optic Neuritis in MS Clinical Trial
Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page
- CheckyesterdayChange DetectedRevision updated: v3.4.3 removed and v3.5.0 added. This is a backend/version change and does not alter the page content or study information.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.4.3 was applied. No user-facing content or functionality changes are evident.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing v3.4.1. No other content appears to be altered.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 has been removed. This appears to be a minor site version label update with no impact on study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page shows a new revision tag: v3.3.4, replacing the previous v3.3.3. This is a minor update with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded a Locations section with Missouri as a study site, replacing the previous Missouri Locations block. The HHS Vulnerability Disclosure link was removed, and the page revision is updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.